Purchase Order 75N95024P00640

<p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>

This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like...

This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian federal agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods. The $92,000.00 contract is for the delivery of a &quot;SINGLE-PLEX NULISAPCR ABSOLUTE QUANTIFICATION ASSAY OF HDGFL2 IN PLASMA SAMPLES.&quot; This contract supports the agency's research into Alzheimer's disease and central nervous system (CNS) disorders, as Alamar Biosciences specializes in providing advanced...

This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...

This is a $20,000.00 firm fixed-price purchase order contract awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods. The contract has a performance period ending on June 23, 2026 and was awarded on June 24, 2025. The contract does not have a set-aside designation, indicating Alamar Biosciences successfully competed for this open market procurement. The award is focused on providing specialized research...

This $1,786,400.00 firm fixed price purchase order contract was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit company specializing in neurological diagnostic services. The contract is for protein analysis services focused on detecting alpha-synuclein aggregates in cerebrospinal fluid samples, utilizing Amprion's proprietary SYNTap assay technology. The contract has a period of...

This is a $100,000.00 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods located in Fremont, California. The contract is for the provision of the NULISASEQ MOUSE PANEL, which involves proteomic mouse panel analysis to investigate potential biomarkers. The award does not have a set-aside designation, indicating open market competition. The contract period runs from...

<p>The U.S. National Institute on Aging (NIA), a civilian federal agency, has awarded a $20,000.00 firm fixed price purchase order contract to Voros Innovation &amp; Business Services PTY LTD, a for-profit organization located in Australia. The contract is for laboratory services related to molecular modeling analysis, and has a period of performance through February 21, 2025. The contract is not set aside for any specific business type.</p>

<p>The National Institute on Aging, a civilian federal agency, awarded a $22,000.00 Firm Fixed Price purchase order to Aristea Translational Medicine Corporation, a for-profit organization. The contract award, with no set-aside designation, is for translational medicine services. The contract has an ultimate completion date of September 18, 2018 and was awarded on July 20, 2018.</p>

The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $27,987.50 firm fixed price delivery order contract to 10X Genomics, Inc., a for-profit manufacturer of life sciences technology products and services. The contract is for the provision of GEM-X Chromium Cell Kits, which are reagents used for single-cell analysis applications. This delivery order is part of a larger indefinite delivery contract valued at up to...